IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 109 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |
| Avidity Partners Management LP | 769,800 | $38,058,912 | 1.26% |
| Samsara BioCapital, LLC | 80,963 | $4,002,811 | 0.83% |
| BRAIDWELL LP | 426,110 | $21,066,878 | 0.70% |
| Rhenman & Partners Asset Management AB | 131,288 | $6,238,806 | 0.68% |
| Baker Brothers Advisors | 2,520,731 | $124,624,941 | 0.68% |
| GENERAL ATLANTIC, L.P. | 950,000 | $46,968,000 | 0.55% |
| HighVista Strategies LLC | 13,194 | $652,311 | 0.53% |
| Pier Capital, LLC | 68,544 | $3,388,815 | 0.51% |
| Dalton Investments, Inc. | 10,000 | $494,400 | 0.43% |
| ARMISTICE CAPITAL, LLC | 378,000 | $18,688,320 | 0.27% |
External links
This page lists IMMUNOCORE HLDGS PLC's shareholders in Q1 2023. To view IMMUNOCORE HLDGS PLC's shareholder history, click here.